Inventor · disambiguated record
Gale Smith
Also filed as: SMITH GALE · SMITH GALE E · SMITH GALE EUGENE · SMITH GALE L
55 granted patents·32 pending applications·2,165 citations·filing 1983–2025
99Inventor score
Top patents by PatentIndex Score
87 records- 0199US10953089B1Coronavirus vaccine formulationsNOVAVAX INC·Filed 2020·Granted Mar 23, 2021·99 cites·20 claims
- 0298US11541112B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2021·Granted Jan 3, 2023·5 cites·20 claims
- 0397US10022437B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2015·Granted Jul 17, 2018·22 cites·16 claims
- 0497US4745051AMethod for producing a recombinant baculovirus expression vectorTEXAS A & M UNIV SYS·Filed 1983·Granted May 17, 1988·519 cites·29 claims
- 0596US12357684B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2022·Granted Jul 15, 2025·2 cites·14 claims
- 0696US11896664B2Corona virus vaccine formulationsNOVAVAX INC·Filed 2022·Granted Feb 13, 2024·2 cites·34 claims
- 0796US11253586B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2021·Granted Feb 22, 2022·4 cites·26 claims
- 0896US11253585B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2019·Granted Feb 22, 2022·8 cites·27 claims
- 0996US8080255B2Functional influenza virus like particles (VLPs)SMITH GALE·Filed 2006·Granted Dec 20, 2011·42 cites·11 claims
- 1096US4879236AMethod for producing a recombinant baculovirus expression vectorTEXAS A & M UNIV SYS·Filed 1987·Granted Nov 7, 1989·384 cites·11 claims
- 1195US10426829B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2016·Granted Oct 1, 2019·17 cites·14 claims
- 1295US8715692B2Modified RSV F proteins and methods of their usePUSHKO PETER·Filed 2009·Granted May 6, 2014·29 cites·19 claims
- 1395US5858368AVaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second proteinPROTEIN SCIENCES CORP·Filed 1995·Granted Jan 12, 1999·255 cites·22 claims
- 1494US9050290B2Functional influenza virus like particles (VLPs)NOVAVAX INC·Filed 2013·Granted Jun 9, 2015·18 cites·36 claims
- 1594US8551756B2Avian influenza chimeric VLPSSMITH GALE·Filed 2010·Granted Oct 8, 2013·25 cites·15 claims
- 1694US8506967B2Functional influenza virus like particles (VLPs)SMITH GALE·Filed 2008·Granted Aug 13, 2013·26 cites·19 claims
- 1794US5762939AMethod for producing influenza hemagglutinin multivalent vaccines using baculovirusMG PMC LLC·Filed 1993·Granted Jun 9, 1998·264 cites·11 claims
- 1893US9180180B2Functional influenza virus-like particles (VLPs)NOVAVAX INC·Filed 2014·Granted Nov 10, 2015·15 cites·25 claims
- 1993US7598075B2Apparatus and methods for producing and using high-density cells and products therefromPROTEIN SCIENCES CORP·Filed 2005·Granted Oct 6, 2009·29 cites·6 claims
- 2092US11446374B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2019·Granted Sep 20, 2022·5 cites·12 claims
- 2192US11052146B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2018·Granted Jul 6, 2021·3 cites·20 claims
- 2292US9675685B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2014·Granted Jun 13, 2017·11 cites·15 claims
- 2392US8951537B2Functional influenza virus-like particles (VLPs)SMITH GALE·Filed 2011·Granted Feb 10, 2015·16 cites·38 claims
- 2491US9731000B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2015·Granted Aug 15, 2017·7 cites·18 claims
- 2591US9717786B2Modified RSV F proteins and methods of their useNOVAVAX INC·Filed 2015·Granted Aug 1, 2017·7 cites·17 claims
- 2691US9623104B2Functional influenza virus-like particles (VLPS)NOVAVAX INC·Filed 2015·Granted Apr 18, 2017·7 cites·15 claims
- 2791US8992939B2Highly efficient influenza matrix (M1) proteinsSMITH GALE·Filed 2011·Granted Mar 31, 2015·16 cites·20 claims
- 2890US9694066B2Functional influenza virus like particles (VLPs)NOVAVAX INC·Filed 2015·Granted Jul 4, 2017·6 cites·16 claims
- 2990US7879601B2Apparatus and methods for producing and using high-density cells and products therefromPROTEIN SCIENCES CORP·Filed 2009·Granted Feb 1, 2011·14 cites·12 claims
- 3089US9937253B2Functional influenza virus-like particles (VLPS)NOVAVAX INC·Filed 2017·Granted Apr 10, 2018·5 cites·15 claims
- 3189US9464276B2Highly efficient influenza matrix (M1) proteinsNOVAVAX INC·Filed 2015·Granted Oct 11, 2016·8 cites·16 claims
- 3289US8697088B2VLPs derived from cells that do not express a viral matrix or core proteinSMITH GALE·Filed 2008·Granted Apr 15, 2014·8 cites·20 claims
- 3388US12491241B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2023·Granted Dec 9, 2025·0 cites·11 claims
- 3488US11364294B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2017·Granted Jun 21, 2022·2 cites·24 claims
- 3588US6103526ASpodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and usingPROTEIN SCIENCES CORP·Filed 1998·Granted Aug 15, 2000·121 cites·16 claims
- 3686US11278612B2Multivalent influenza nanoparticle vaccinesNOVAVAX INC·Filed 2019·Granted Mar 22, 2022·3 cites·20 claims
- 3786US6245532B1Method for producing influenza hemagglutinin multivalent vaccinesPROTEIN SCIENCES CORP·Filed 1998·Granted Jun 12, 2001·84 cites·10 claims
- 3885US12472246B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2022·Granted Nov 18, 2025·0 cites·12 claims
- 3982US12257297B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2022·Granted Mar 25, 2025·0 cites·30 claims
- 4082US11123419B2Methods and compositions for inducing immune responses against Clostridium difficileNOVAVAX INC·Filed 2018·Granted Sep 21, 2021·1 cites·22 claims
- 4182US10188723B2Functional influenza virus like particles (VLPs)NOVAVAX INC·Filed 2017·Granted Jan 29, 2019·2 cites·17 claims
- 4282US9381239B2VLPS derived from cells that do not express a viral matrix or core proteinNOVAVAX INC·Filed 2014·Granted Jul 5, 2016·2 cites·21 claims
- 4380US12083228B2Methods and compositions for treating respiratory diseaseNOVAVAX INC·Filed 2018·Granted Sep 10, 2024·1 cites·18 claims
- 4480US8795682B2Virus-like particles comprising chimeric human immunodeficiency virus (HIV)/mouse mammary tumor virus (MMTV) envelopesCOMPANS RICHARD W·Filed 2008·Granted Aug 5, 2014·4 cites·13 claims
- 4577US2024423926A1Methods and compositions for treating respiratory diseaseNOVAVAX INC·Filed 2024·Application pending·0 cites
- 4675US9951317B2Highly efficient influenza matrix (M1) proteinsNOVAVAX INC·Filed 2016·Granted Apr 24, 2018·1 cites·20 claims
- 4775US2024293530A1Multivalent influenza nanoparticle vaccinesNOVAVAX INC·Filed 2024·Application pending·0 cites
- 4874US10751410B2Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV) compositions and methodsNOVAVAX INC·Filed 2014·Granted Aug 25, 2020·1 cites·18 claims
- 4973US6224882B1Insect cells or fractions as adjuvant for antigensPROTEIN SCIENCE CORP·Filed 1997·Granted May 1, 2001·60 cites·65 claims
- 5072US9724405B2Rabies glycoprotein virus-like particles (VLPS)SMITH GALE·Filed 2011·Granted Aug 8, 2017·1 cites·18 claims
Showing the top 50 of 87 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gale Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →